Virpax Pharmaceuticals, Inc.
SEC CIK 1708331 · VRPX · last insider filing 2025-01-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Panis Jaydriane | Director | filed 2025 - 2025 |
| Randhawa Esha | Director | filed 2024 - 2024 |
| Su Judy | Director | filed 2024 - 2024 |
| Field Katharyn | Director | filed 2024 - 2024 |
| Herman Gary L | Director | filed 2024 - 2024 |
| Dhaliwal Jatinder | Director | filed 2024 - 2024 |
| Bruce Gerald W | Director · EVP, Commercial Operations | filed 2021 - 2024 |
| Singh Vanila | Director | filed 2021 - 2024 |
| Jambulingam Thani | Director | filed 2021 - 2024 |
| Floyd Eric | Director | filed 2021 - 2024 |
| Sendrow Jerrold | Director | filed 2021 - 2024 |
| Dubin Michael F | Director | filed 2021 - 2024 |
| Ruskin Barbara | Director | filed 2023 - 2024 |
| Mack Anthony P. | Director · Chief Executive Officer | filed 2021 - 2023 |
| Gudin Jeffrey | Director · Chief Medical Officer | filed 2021 - 2023 |
| Jacob Gary S | Director | filed 2021 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Chaudhry Usama | Chief Financial Officer | filed 2025 - 2025 |
| Shah Vinay | Chief Financial Officer | filed 2023 - 2024 |
| Mathias Sheila | Chief Scientific Officer | filed 2023 - 2024 |
| Chipman Christopher Michael | Chief Financial Officer | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.